中文简介

化学制剂是一本同行评议的普通化学杂志，它为读者带来了以化学为中心的多学科研究的最佳成果。化学制剂在其范围内全面发表文章，涵盖化学或化学的两个不同方面（子领域）或另一个科学学科（一个化学主题加上另一个，因此标题为化学制剂）的新成果。所有合适的提交文件都经过该领域专家的平衡同行评审，以确保最高的质量、原创性、相关性、重要性和有效性化学制剂提供…短出版时间，以接受文章（已提交；应作者要求）和早期查看（记录的排版版本）状态持续出版，更快地提供最终和可引用的文章免费复制彩色图形综合了全文、通信、评论和小评论包括简介、特殊问题和虚拟问题通过编辑经理提交和管理稿件在所有提交文件中应用iFective软件以确保真实性和独创性。威利VCH期刊编辑部之间密切合作，确保高质量的研究能找到最合适的论坛。通过联机开放程序打开访问发布适用于iphoness/ipads和androids的免费应用程序通过社交媒体推广内容：Twitter、Facebook《化学观点》和《高等科学新闻》选文的突出通过早期职业系列和相关访谈支持未来的主要研究人员

投稿网址：http://www.editorialmanager.com/cplu/default.aspx

英文简介

ChemPlusChem is a peer-reviewed, general chemistry journal that brings readers the very best in multidisciplinary research centering on chemistry. Fully comprehensive in its scope, ChemPlusChem publishes articles covering new results from at least two different aspects (subfields) of chemistry or one of chemistry and one of another scientific discipline (one chemistry topic plus another one, hence the title ChemPlusChem). All suitable submissions undergo balanced peer review by experts in the field to ensure the highest quality, originality, relevance, significance, and validity.ChemPlusChem offers...short publication times to Accepted Article (as-submitted; at authors' request) and EarlyView (typeset version of record) statuscontinuous publishing making final and citable articles available fasterfree reproduction of color graphicsa mix of Full Papers, Communications, Reviews and Minireviewscover profiles, special issues and virtual issuesmanuscript submission and management through Editorial Managerthe application of iThenticate software to all submissions to ensure authenticity and originalityclose cooperation between the editorial offices of Wiley-VCH journals to ensure that high-quality research will find the most appropriate forumopen access publishing through the OnlineOpen programa free app for iphoness/ipads and androidspromotion of content through social media: Twitter, Facebookhighlighting of selected articles in ChemistryViews and Advanced Science Newssupport for leading researchers of the future through the Early Career Series and associated Interviews